Research in Radiology
In abdominal radiology, there are multiple ongoing projects to develop new CT and MRI-methods to quantify organ function as well as to diagnose cancer earlier. Also, our aim is to improve staging and evaluation of tumor response to treatment.
Our research profile is in line with the profile of our hospital, i.e. transplantation and upper abdominal surgery. Principles of the so-called ”precision medicine” (i.e., the right patient is provided with the right treatment at the right time) play a central role. Research group leaders are associate professor Torkel Brismar and Nikolaos Kartalis, M.D., Ph.D. Below are some examples of the ongoing projects in the Division of Radiology at CLINTEC:
CT of a solid tumor in the liver or pancreas with very high temporal resolution after the injection of iodine-based contrast media, we try to improve characterization and/or predict/assess earlier whether the tumor will respond to therapy or not.
Optimization of contrast media dose at CT
In order to improve visualization of organs and their diseases, we administer intravenously iodine-based contrast agents. In these projects, we try to optimize the amount of contrast agent to patient size/ composition and heart function in order to inject a sufficient amount of contrast agent at an appropriate rate for the specific clinical setting.
Esophageal and colon cancer
CT-based analysis of tumors’ morphometric structure may improve our ability to identify which patients have aggressive tumors and who will have a good response to treatment. This can potentially save patients that have responded well to non-surgical treatment from surgery (regarding esophageal cancer) and/or lead to a timely change to other forms of treatment in those patients whose tumors did not respond to standard treatment.
CT and MRI are used to improve detection, staging and characterization of solid and cystic pancreatic tumors. Furthermore, we investigate pancreatic function by injecting a substance similar to a body hormone (namely, secretin) and then quantifying the excretion of pancreatic fluid on MRI images.
Primary sclerosing cholangitis (PSC)
In patients with PSC, there is a chronic inflammation of the bile ducts. The inflammatory changes lead to a progressive destruction of parts of the liver and predispose to cholangiocarcinoma. By applying advanced post-processing of MR images, we try to predict which patients have a high risk to develop a clinically significant liver function deterioration or cholangiocarcinoma.
There are many diseases that lead liver function deterioration, such as inflammation (hepatitis), diabetes mellitus, obesity and alcoholism. Chemotherapy may also lead to liver dysfunction. In order to assess treatment effect and estimate the proportion of liver that needs to remain within the body after liver surgery, it is important to calculate the degree of fatty infiltration, fibrosis and function of the liver. We try to quantify all these parameters by analyzing how the MRI signals of fat and water interact with each other, how fast a shake-wave propagates through the liver parenchyma (the so called “MR elastography”) and by calculating the excretion of hepatobiliary-specific contrast agents.
Diagnostic and interventional oncologic radiology (DIOR)
Primary tumors and metastases may be treated microinvasively through heating (thermal ablation), freezing (cryoablation) and direct alcohol injection. Proper positioning of the needle/probe is performed under ultrasound or CT guidance. Some tumors maybe difficult to identify either because they are too small and/or they are only visible during a particular phase at dynamic contrast-series, or at MRI. In this project, we fuse images from CT or MRI with ultrasound. Thus, advantages of both techniques can be combined, such as the high spatial resolution of CT/MRI with the real-time imaging of ultrasound. In order to achieve needle/probe placement in very small tumors, minimizing respiratory-related motion is necessary. For that, patients may have a general anesthesia and receive high-frequency jet ventilation.
Primary investigators are Torkel Prismar and Nikolaos Kartalis.
Musculoskeletal research is mainly is focused on studies on osteoporosis and body composition and is lead by Torkel Brismar.
In nuclear medicine, we have a wide cooperation in different fields: infectious diseases, orthopedics, gastro surgeons, urologists, transplant surgeons, stem cell researchers, and neurologists. Much of the research is devoted to using hybrid imaging with SPECT / CT and PET / CT for early diagnosis, staging, and monitoring the effect of treatment in oncology as well as neuroscience in geriatrics and orthopedics / infection. In the current situation there are six Ph. D students in these field; and we have two PhD doctor, and a registered Ph. D student employed in this section. Research leader is Professor Rimma Axelsson
Below is a selection of projects
- Hybrid imaging SPECT/CT
- MIDOR – Molecular imaging in Differentiation of Oncocytoma from Renal Cell carcinoma
- Hybrid imaging with PET/CT
- Evaluation of treatment effects with proliferation marker 18F-FLT in patients with esophageal carcinoma.
- Natural History of healing after Prosthetic surgery followed by 18 F-FDG-WBC PET / CT
o infections in orthopedic prostheses - comparative study of 18 F-FDG-WBC with SPECT / CT and 99mTc-HMPAO
- WBC with SPECT / CT
- 68Ga-PSMA-11 PET/CT in high risk patients with primary prostate cancer
- 68Ga-PSMA-11 PET/CT in patients with biochemical relapse of prostate cancer
Regarding the cardiovascular area, we have a close cooperation with cardiologists and a great deal of research has been devoted to establishing and developing the method of CT of the coronary arteries (CTA) with ECG-triggered technology. This led in 2011 to the thesis ”Computed tomography of the coronary arteries ” by Jonaz Ripsweden.
Today, research is partly focused on CTA in the study SMINC 2, which is collaboration between 5 Stockholm hospitals. We examine the coronary arteries of all MINOCA patients in Stockholm who have suffered a heart attack but have no angiographic stenoses (Myocardial Infarction with Non-Obstuctive coronary angiography). The goal is to find out what this state consists of and how to prevent it. The radiological part of SMINC 1 led in 2015 to the thesis "Coronary computed tomography in patient with myocardial infarction and non-obstructed coronary arteries" by Elin Bacsovics.
Research in contrast optimization in CTA led in 2015 to the thesis "Intravenous contrast media optimization at computed tomography" by Anders Svensson.
We have research collaboration with cardiothoracic surgeons and cardiologists regarding time-resolved studies (so called 4D technology) of percutaneously and surgically implanted biological aortic valves to study thrombosis and reduced mobility of the leaflets in the postoperative course.
Research leader is Docent Kerstin Cederlund.
Since April 2015 we have carried out CT scans of coronary arteries, lungs and body composition in 5000 subjects between 50 and 65 years in the national study SCAPIS. This is done in the radiology department at Karolinska Huddinge.